Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Biotech
Sort By
Newest First
1 / 3
1 / 3
Announcement
CellFE® Announces Strategic Placements with Leading Pharma and Biotech Companies
CellFE
PR-12-24-NI-143
Dec 19, 2024
Regulatory
Adapting Medical Information Services to Japan’s Distinct Needs
Jim Leaver, Ph.D.
PrimeVigilance
PAO-11-24-CL-03
Nov 22, 2024
Gene Silencing
‘Gene silencing’ therapies market set to boom, says leading biotech
SynaptixBio
PR-11-24-NI-115
Nov 20, 2024
biotechnology
Atlas Venture targets $450M for 14th biotech fund, the same size as its 2022 raise
Atlas Venture
PR-11-24-NI-111
Nov 18, 2024
Bioscience
Neurocrine Biosciences Presents Breadth of Data Over Time Following Treatment With INGREZZA Capsules
Neurocrine Biosciences
PR-10-24-NI-71
Nov 04, 2024
Nice Insight Reports
Biotech Funding Ups and Downs
April Stanley, MS MBA
Nice Insight
PAO-04-24-NI-01
Apr 02, 2024
Alloy Therapeutics and Wheeler Bio Announce Preferred Service Offering for Alloy Partners to Accelerate the Translation from Discovery to CMC
Wheeler Bio
PR-M11-23-01
Nov 08, 2023
Wheeler Bio Announces Grand Opening of Biomanufacturing Facility
Wheeler Bio
PR-M10-23-01
Oct 05, 2023
Immuno-Oncology
Targeted Immune System Activation: A Paradigm Shift in Immuno-oncology
Dan Passeri, M.Sc., J.D.
Cue Biopharma
PAO-12-022-CL-01
Jan 04, 2023
Synthetic Biology
Synthetic Biology: A Potential Game-Changer for the Biopharma Industry
Cynthia A. Challener, Ph.D.; David Alvaro, Ph.D.
Pharma's Almanac
PAO-12-022-NI-01
Dec 23, 2022
Digital Therapeutics
Digital Therapeutics and the Song of the Future of Healthcare
Chris E. Rivera; Xavier A. Figueroa
EMulate Therapeutics
PAO-12-022-CL-02
Dec 20, 2022
Hemostatic
Stopping Bleeds and Saving Lives
Joe Landolina
Cresilon
PAO-11-022-CL-09
Nov 16, 2022
Plant-Inspired Drug Discovery
Unlocking the Therapeutic Potential of Plant-Inspired Minimum Essential Mixtures
Andrea Small-Howard, Ph.D.
Gb Sciences, Inc.
PAO-08-022-CL-01
Sep 06, 2022
Life Science Industrials
Life Science Industrials Are Key to the Growth of the Biopharma Industry
Reinhard Vogt
Dynamk Capital
PAO-07-022-CL-05
Aug 04, 2022
New Division
Olon Presents Olon Biotech, A New Division Operating by Biotechnological Processes
Olon
PR-M07-22-03
Jul 12, 2022
Column: Investment
IPOs Have Not Recovered In 2022. When Will Biotech Bounce Back?
Danielle Alvarez
Pharma's Almanac
PAO-06-022--NI-02
Jun 24, 2022
Biotechs
10 More Biotechs Making Moves in 2022
David Alvaro, Ph.D.; Danielle Alvarez
Pharma's Almanac
PAO-06-022--NI-07
Jun 24, 2022
Enabling Drug Discovery Targeting Ion Channels
Doug Krafte, Ph.D.
Icagen
Ion Channels
May 19, 2022
Global License Agreement
Hovione and JIXING Announce an Exclusive Global License Agreement for Ophthalmology Program
Hovione
PR-M05-22-04
May 09, 2022
Investment
Bringing Value to Pharma and Biopharma
Commercial Healthcare Partners
PAO-04-22-R250-75
Apr 29, 2022
